Occudo Quantitative Strategies LP Satsuma Pharmaceuticals, Inc. Transaction History

Occudo Quantitative Strategies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.15 - $6.24 $45,006 - $67,672	-10,845 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.54 - $7.17 $4,326 - $6,833	-953 Reduced 8.08%	10,845 $51,000
Q2 2021 Aug 16, 2021	SELL	$4.8 - $7.25 $10,128 - $15,297	-2,110 Reduced 15.17%	11,798 $83,000
Q4 2020 Feb 16, 2021	BUY	$3.56 - $5.09 $49,512 - $70,791	13,908 New	13,908 $64,000

Ticker STSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,587,500
Description
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.